Ocugen pulls the plug on Covaxin, turns its attention to an inhaled Covid-19 vaccine

Ocugen has concluded that "the development of Covaxin in North America is not commercially viable."

Source: bizjournals.com Health Care News Headlines - May 5, 2023 Category: Health Management Authors: John George Source Type: news